Lovastatin Tablet
Product Images NDC 50090-0761

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 50090-0761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500900761)

Lovastatin 40 mg oral tablets label from A-S Medication Solutions. The label includes the product name, strength (40 mg), quantity of 30 tablets, storage instructions (store at 68 to 77 degrees F, protect from light), and a 2D barcode. The label also shows the product NDC 50090-0761 and lot number field.*

FDA Label Image

Structural Formula (Lov00 0004 01)

Chemical structure diagram of lovastatin showing its molecular configuration with various rings, hydroxyl, and methyl groups visible in the illustrated compound.*

FDA Label Image

Table I (Lov00 0004 02)

A data table titled 'The Effect of Other Drugs on Lovastatin Exposure When Both Were Co-administered,' showing the number of subjects, dosing of coadministered drugs or grapefruit juice, dosing of Lovastatin, and AUC ratios (area under the curve) for Lovastatin and total Lovastatin acid. The table compares coadministration with various drugs including Gemfibrozil, Itraconazole, Grapefruit Juice (high and low dose), Cyclosporine, and Diltiazem.*

FDA Label Image

Figure 1 (Lov00 0004 03)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over six years of follow-up. The graph compares two groups labeled Lovastatin and Placebo, indicating a 37% risk reduction for the Lovastatin group with a significant p-value (p < 0.001). The y-axis represents the proportion of participants without event, ranging approximately from 0.90 to 1.0, and the x-axis shows years of follow-up from 0 to 6.*

FDA Label Image

Table Vii (Lov00 0005 04)

A data table titled 'Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis' listing interacting agents such as strong CYP3A4 inhibitors, HIV protease inhibitors, gemfibrozil, cyclosporine, specific drugs like danazol, diltiazem, dronedarone, verapamil, amiodarone, and grapefruit juice, alongside prescribing recommendations for use with lovastatin. Recommendations include contraindications, dose limits, and avoidance advice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.